Systemic bioavailability of fluticasone in COPD.
Lipworth
Brian J
BJ
Menzies
Daniel
D
D000280:Administration, Inhalation; D000730:Androstadienes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001682:Biological Availability; D002097:C-Reactive Protein / Q000187:drug effects* / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D000068298:Fluticasone; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000188:drug therapy*; D016896:Treatment Outcome
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D002097:C-Reactive Protein; D000068298:Fluticasone